KPIs & Operating Metrics(New)
Breakdown Of AssetsEmployee StatisticsFixed Assets, Net BreakdownGross Margin %Gross Margin Annual %Gross ProfitGross Profit AnnualIncome (Loss) Before Income TaxLicense Revenue By Category AnnualOpex As A % Of Total Revenue %OPEX SegregationProduct Revenue By CategoryProduct Revenue By Category AnnualProfitabilityProfitability %Profitability AnnualProfitability Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Trx By Product
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Gross Profit (2016 - 2025)

TherapeuticsMD's Gross Profit history spans 13 years, with the latest figure at $502000.0 for Q4 2023.

  • For Q4 2023, Gross Profit fell 99.27% year-over-year to $502000.0; the TTM value through Dec 2023 reached $1.3 million, down 98.43%, while the annual FY2023 figure was $1.3 million, 98.1% down from the prior year.
  • Gross Profit reached $502000.0 in Q4 2023 per TXMD's latest filing, up from -$53000.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $68.6 million in Q4 2022 to a low of -$53000.0 in Q3 2023.
  • Average Gross Profit over 5 years is $13.6 million, with a median of $13.5 million recorded in 2019.
  • Peak YoY movement for Gross Profit: soared 702.7% in 2019, then tumbled 99.27% in 2023.
  • A 5-year view of Gross Profit shows it stood at $13.0 million in 2019, then soared by 30.52% to $17.0 million in 2020, then dropped by 17.98% to $13.9 million in 2021, then skyrocketed by 391.83% to $68.6 million in 2022, then crashed by 99.27% to $502000.0 in 2023.
  • Per Business Quant, the three most recent readings for TXMD's Gross Profit are $502000.0 (Q4 2023), -$53000.0 (Q3 2023), and $437000.0 (Q2 2023).